» Articles » PMID: 27598536

Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS

Overview
Journal Radiology
Specialty Radiology
Date 2016 Sep 7
PMID 27598536
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose To compare three metrics of breast density on full-field digital mammographic (FFDM) images as predictors of future breast cancer risk. Materials and Methods This institutional review board-approved study included 125 women with invasive breast cancer and 274 age- and race-matched control subjects who underwent screening FFDM during 2004-2013 and provided informed consent. The percentage of density and dense area were assessed semiautomatically with software (Cumulus 4.0; University of Toronto, Toronto, Canada), and volumetric percentage of density and dense volume were assessed automatically with software (Volpara; Volpara Solutions, Wellington, New Zealand). Clinical Breast Imaging Reporting and Data System (BI-RADS) classifications of breast density were extracted from mammography reports. Odds ratios and 95% confidence intervals (CIs) were estimated by using conditional logistic regression stratified according to age and race and adjusted for body mass index, parity, and menopausal status, and the area under the receiver operating characteristic curve (AUC) was computed. Results The adjusted odds ratios and 95% CIs for each standard deviation increment of the percentage of density, dense area, volumetric percentage of density, and dense volume were 1.61 (95% CI: 1.19, 2.19), 1.49 (95% CI: 1.15, 1.92), 1.54 (95% CI: 1.12, 2.10), and 1.41 (95% CI: 1.11, 1.80), respectively. Odds ratios for women with extremely dense breasts compared with those with scattered areas of fibroglandular density were 2.06 (95% CI: 0.85, 4.97) and 2.05 (95% CI: 0.90, 4.64) for BI-RADS and Volpara density classifications, respectively. Clinical BI-RADS was more accurate (AUC, 0.68; 95% CI: 0.63, 0.74) than Volpara (AUC, 0.64; 95% CI: 0.58, 0.70) and continuous measures of percentage of density (AUC, 0.66; 95% CI: 0.60, 0.72), dense area (AUC, 0.66; 95% CI: 0.60, 0.72), volumetric percentage of density (AUC, 0.64; 95% CI: 0.58, 0.70), and density volume (AUC, 0.65; 95% CI: 0.59, 0.71), although the AUC differences were not statistically significant. Conclusion Mammographic density on FFDM images was positively associated with breast cancer risk by using the computer assisted methods and BI-RADS. BI-RADS classification was as accurate as computer-assisted methods for discrimination of patients from control subjects. RSNA, 2016.

Citing Articles

Effect of patient age and breast parenchymal density on Breast Imaging-Reporting and Data System (BIRADS-4) Subcategorization.

Ghunaim H Pak J Med Sci. 2024; 40(10):2356-2362.

PMID: 39554642 PMC: 11568739. DOI: 10.12669/pjms.40.10.9552.


Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.

Fabian C, Mudaranthakam D, Gajewski B, Young K, Winblad O, Khan S Contemp Clin Trials. 2024; 146():107697.

PMID: 39293780 PMC: 11756487. DOI: 10.1016/j.cct.2024.107697.


Association of mammographic breast density measurements and hormone receptor status of breast cancer.

Priti S, Dixit R, Garg A, Khurana N, Singh R Pol J Radiol. 2024; 89:e273-e280.

PMID: 39040562 PMC: 11262017. DOI: 10.5114/pjr/187679.


Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammography.

Watt G, Keshavamurthy K, Nguyen T, Lobbes M, Jochelson M, Sung J JNCI Cancer Spectr. 2024; 8(3).

PMID: 38565262 PMC: 11060476. DOI: 10.1093/jncics/pkae026.


Breast density analysis of digital breast tomosynthesis.

Heine J, Fowler E, Weinfurtner R, Hume E, Tworoger S Sci Rep. 2023; 13(1):18760.

PMID: 37907569 PMC: 10618274. DOI: 10.1038/s41598-023-45402-x.


References
1.
Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M . Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014; 16(5):439. PMC: 4303120. DOI: 10.1186/s13058-014-0439-1. View

2.
Boyd N, Rommens J, Vogt K, Lee V, Hopper J, Yaffe M . Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005; 6(10):798-808. DOI: 10.1016/S1470-2045(05)70390-9. View

3.
Vickers A, Cronin A, Begg C . One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol. 2011; 11:13. PMC: 3042425. DOI: 10.1186/1471-2288-11-13. View

4.
Keller B, Nathan D, Gavenonis S, Chen J, Conant E, Kontos D . Reader variability in breast density estimation from full-field digital mammograms: the effect of image postprocessing on relative and absolute measures. Acad Radiol. 2013; 20(5):560-8. PMC: 3673702. DOI: 10.1016/j.acra.2013.01.003. View

5.
Pisano E, Zuley M, Baum J, Marques H . Issues to consider in converting to digital mammography. Radiol Clin North Am. 2007; 45(5):813-30, vi. PMC: 2078259. DOI: 10.1016/j.rcl.2007.06.007. View